🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary trial objective in this single arm trial is to assess the safety an...
Status
Completed
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Start Date
2009-04
Trial ID
NCT00879866
Treatments Being Tested
A phase IV study to characterize safety of Elunate® (Fruquintinib) in Chine...
Status
Completed
Location
Shanghai Dongfang Hospital
Start Date
2019-04-20
Trial ID
NCT04005066
Treatments Being Tested
Health care workers working in hospital or nursing home for elderly people ...
Status
Completed
Location
Centre Investigation Clinique 1415
Start Date
2020-11-20
Trial ID
NCT04570202
Treatments Being Tested
ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharm...
Status
Completed
Location
Frontage Clinical Services
Start Date
2020-02-17
Trial ID
NCT04220801
Treatments Being Tested
The primary endpoint is to determine if ECP induces a decrease in % of tumo...
Status
Recruiting
Location
Emory University School of Medicine
Start Date
2023-04-04
Trial ID
NCT05157581
Treatments Being Tested
Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Status
Recruiting
Location
Research Site
Start Date
2023-07-28
Trial ID
NCT06068049
The objective of this study is to assess the efficacy, safety of MRG003 as ...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2020-09-04
Trial ID
NCT04838548
Treatments Being Tested
This trial is divided into two parts, a dose-escalation study (phase 1) and...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2013-08
Trial ID
NCT01933815
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, dose-E...
Status
Completed
Location
Allife Medicine （Beijing） Limitied
Start Date
2023-08-24
Trial ID
NCT05993884